首页 | 本学科首页   官方微博 | 高级检索  
     


Adverse Drug Events in the Oral Cavity
Affiliation:1. Division of Oral Medicine, Tufts University School of Dental Medicine, 1 Kneeland Street, Boston, MA 02111, USA;2. Division of Oral Medicine and Dentistry, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA;3. Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, MA 02115, USA;1. Division of Oral Medicine and Dentistry, Brigham and Women’s Hospital, 1620 Tremont St, Suite 3-02B, Boston, MA 02120, USA;2. Center for Integrative Oral Health Inc., 7151, University Boulevard, Unit 110, Winter Park, FL 32792, USA;3. University of North Carolina-Chapel Hill, Adams School of Dentistry, Campus Box 7450, Chapel Hill, NC 27599-7450, USA;4. University of North Carolina-Chapel Hill, Adams School of Dentistry, Chapel Hill, NC 27599-7450, USA;1. Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, 240 South 40th Street, Philadelphia, PA 19104, USA;2. Department of Orofacial Sciences, University of California San Francisco, 513 Parnassus Avenue, Suite 512A, San Francisco, CA 94143, USA;1. U.S. Navy, San Diego, CA, USA;2. Department of Oral Medicine, University of Pennsylvania, Penn Dental Medicine, 240 South 40th Street, Room 206, Schattner Building, Philadelphia, PA 19104, USA;3. Department of Dermatology, University of Pennsylvania, 822 Pine Street Suite 2A, Philadelphia, PA 19107, USA;1. Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France;2. Clinical Pharmacology Department, Grenoble Alpes University Hospital, INSERM CIC1406, Grenoble, France;3. Univ. Grenoble Alpes, UMR 1042–HP2, INSERM, Grenoble, France;4. Department of Medical and Clinical Pharmacology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France;5. Assistance Publique–Hôpitaux de Paris, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre and Université Paris-Sud, Laboratoire d’Excellence en Recherche sur le Médicament et Innovation Thérapeutique and INSERM Unité 999, Le Kremlin–Bicêtre, France;1. Department of Basic and Translational Sciences, University of Pennsylvania School of Dental Medicine, 240 South 40th Street, Philadelphia, PA 19104, USA;2. Department of Dermatology, Hospital of the University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA 19104, USA;3. Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, 240 South 40th Street, Philadelphia, PA 19104, USA
Abstract:
Keywords:Adverse drug events  Drug-related side effects  Adverse reactions  Medications  Oral cavity  Targeted therapies
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号